Hydrocortison Orion Corporation (Hydrocortisone)

Hydrocortison Orion Corporation is indicated for the topical treatment of several inflammatory skin disorders.

• Dermatitis, including atopic and contact types
• Eczema (atopic dermatitis)
• Psoriasis plaques
• Seborrheic dermatitis
• Other inflammatory skin conditions such as lichen planus

• Hydrocortison Orion Corporation delivers hydrocortisone to the skin, where it binds to intracellular glucocorticoid receptors. This receptor activation modulates gene transcription, leading to decreased production of pro‑inflammatory cytokines, prostaglandins, and leukotrienes. The result is reduced vascular permeability, inhibition of immune cell migration, and overall suppression of the local inflammatory response.

Adverse reactions may occur with topical hydrocortisone use. They are generally categorized by frequency and severity.

Common

• Mild skin irritation or burning sensation
• Pruritus at the application site
• Dryness or peeling of the skin
• Erythema or mild redness
• Folliculitis

Serious

• Contact dermatitis or allergic reaction
• Skin atrophy with prolonged use
• Secondary bacterial, fungal, or viral infection
• Hypersensitivity systemic reactions (rare)

Before using Hydrocortison Orion Corporation, consider the following safety points.

• Avoid application on broken, infected, or ulcerated skin unless directed by a healthcare professional.
• Limit use on large surface areas or under occlusive dressings to reduce systemic absorption.
• Do not use on the face, groin, or axillae for extended periods without medical supervision.
• Discontinue if signs of allergic reaction or worsening skin condition appear.
• Consult a physician before use during pregnancy, lactation, or in pediatric patients.
• Store at room temperature, protected from moisture and heat.

Topical hydrocortisone can interact with other substances applied to the skin or systemic medications.

Avoid

• Concurrent use of other potent topical corticosteroids on the same area, which may increase risk of skin atrophy.
• Application of topical antibiotics or antifungals that may be inactivated by the steroid's immunosuppressive effect.

Use with caution

• Systemic corticosteroids, as combined effects may increase systemic exposure.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) applied topically, which could heighten irritation.
• Immunosuppressive agents (e.g., cyclosporine) that may amplify infection risk.
• Phototherapy, since steroids can alter skin response to UV light.